Detection of contamination with antineoplastic agents in a hospital pharmacy department
- PMID: 1553250
- DOI: 10.1007/BF01989220
Detection of contamination with antineoplastic agents in a hospital pharmacy department
Abstract
The contamination with fluorouracil, cyclophosphamide and methotrexate was studied in a hospital pharmacy department where these drugs were prepared. In the preparation room, air samples were taken before and during preparation of the drugs. Methotrexate was detected in one sample which was collected during preparation (0.3 micrograms/m3). Spot samples were taken in the vertical laminar airflow safety hood before and after preparation of the drugs and after cleaning of the hood. Contamination of the laminar airflow hood was: cyclophosphamide: 1-160 ng/cm2; fluorouracil: 10-62 ng/cm2 and methotrexate: 2-633 ng/cm2. Spot samples from the floor in front of and beneath the laminar airflow hood showed contamination with especially fluorouracil (48-236 micrograms/m2). The gloves used during preparation of the drugs were contaminated mainly with fluorouracil (5-980 ng/cm2). Urine samples from two workers involved in the preparation of the drugs were analysed for unmetabolized cyclophosphamide; it was not detected. Although no uptake of cyclophosphamide was established, it is shown that the methods for measurement of cyclophosphamide, fluorouracil and methotrexate in the preparation room are applicable for the control of occupational exposure to these drugs.
Similar articles
-
Occupational exposure to antineoplastic agents at several departments in a hospital. Environmental contamination and excretion of cyclophosphamide and ifosfamide in urine of exposed workers.Int Arch Occup Environ Health. 1992;64(2):105-12. doi: 10.1007/BF00381477. Int Arch Occup Environ Health. 1992. PMID: 1399019
-
Comparison of surface contamination with cyclophosphamide and fluorouracil using a closed-system drug transfer device versus standard preparation techniques.Am J Health Syst Pharm. 2006 Sep 15;63(18):1736-44. doi: 10.2146/ajhp050258. Am J Health Syst Pharm. 2006. PMID: 16960258
-
The assessment of environmental and external cross-contamination in preparing ready-to-administer cytotoxic drugs: a comparison between a robotic system and conventional manual production.Int J Pharm Pract. 2020 Feb;28(1):66-74. doi: 10.1111/ijpp.12575. Epub 2019 Sep 6. Int J Pharm Pract. 2020. PMID: 31489970 Free PMC article.
-
Evidence of exposure to cytostatic drugs in healthcare staff: a review of recent literature.Farm Hosp. 2016 Nov 1;40(n06):604-621. doi: 10.7399/fh.2016.40.6.9103. Farm Hosp. 2016. PMID: 27894231 Review. English.
-
External contamination of commercial containers by antineoplastic agents: a literature review.Eur J Hosp Pharm. 2020 Sep;27(5):313-314. doi: 10.1136/ejhpharm-2018-001705. Epub 2019 Jan 19. Eur J Hosp Pharm. 2020. PMID: 32839267 Free PMC article. Review.
Cited by
-
Development of a new method for sampling and monitoring oncology staff exposed to cyclophosphamide drug.Environ Monit Assess. 2016 Apr;188(4):238. doi: 10.1007/s10661-016-5255-x. Epub 2016 Mar 22. Environ Monit Assess. 2016. PMID: 27003403
-
Pilot Evaluation of Dermal Contamination by Antineoplastic Drugs among Hospital Pharmacy Personnel.Can J Hosp Pharm. 2011 Sep;64(5):327-32. doi: 10.4212/cjhp.v64i5.1067. Can J Hosp Pharm. 2011. PMID: 22479084 Free PMC article.
-
Occupational exposure to cytotoxic drugs in two UK oncology wards.Occup Environ Med. 2002 Sep;59(9):608-12. doi: 10.1136/oem.59.9.608. Occup Environ Med. 2002. PMID: 12205233 Free PMC article.
-
A study protocol for the evaluation of occupational mutagenic/carcinogenic risks in subjects exposed to antineoplastic drugs: a multicentric project.BMC Public Health. 2011 Mar 30;11:195. doi: 10.1186/1471-2458-11-195. BMC Public Health. 2011. PMID: 21450074 Free PMC article.
-
Reduction in surface contamination with antineoplastic drugs in 22 hospital pharmacies in the US following implementation of a closed-system drug transfer device.J Oncol Pharm Pract. 2011 Mar;17(1):39-48. doi: 10.1177/1078155210361431. Epub 2010 Feb 15. J Oncol Pharm Pract. 2011. PMID: 20156932 Free PMC article.